Huda Alfardus
Chief Executive Officer of PreClass Company.
|
Name in Arabic:
هدى الفردوس
|
|
|---|---|
|
Nationality:
Saudi
|
|
|
Country of Residence:
Saudi Arabia
|
|
Huda Alfardus's Bio
Chief Executive Officer of PreClass Company, Saudi Arabia.
She is the founder and CEO of My IP Accelerator since September 2025, the managing director of Innovation 360 Group AB in Saudi Arabia since May 2026, and Honorary Research Fellow at University College London.
She is the first Saudi specialist in genomic medicine.
She has held several positions at the Saudi National Bank, including: Business Centre of Excellence Consultant, and Head Of Innovation & Strategy - Neo Digital Bank. She was also a CVC Fund Founding Member - Neo Ventures.
She founded the HEALTHGENA a biotechnology innovation accelerator, and served as its CEO, co-founded the Internet of Things Academy Ltd and served as its CEO, and was an investment partner and regional advisor at the 7BC Venture Capital.
She worked at King Abdullah University of Science and Technology (KAUST), where she held several positions, including: Lab Manager, Academic Supervisor (MSc/PhD students), and Senior Research Fellow in Genomics, in addition to being a member of the university's Scientific Review Committee.
She was also a Data Monetization Advisor at the Saudi Health Council, an Associate Teaching Fellow of The Higher Education Academy at the University of Leeds, and a Heart Research UK (HRUK) Research Fellow in Cardiovascular Genetics and Genomics at the same university. In addition, she worked as Research Placement Supervisor at the Nuffield Foundation and an Academic Co-Supervisor (BSc Research Projects) at the Nottingham University Hospitals NHS Trust in the UK.
Al-Ferdous specializes in the knowledge economy, investment in education and health, human capital development, and human genetics, and has a number of published articles in "Maal Newspaper."
She has written and co-authored several research papers on microRNA regulation in glioblastoma, intra-tumor heterogeneity, and cancer metabolic regulation, published in international journals.
She holds a PhD, In Genomics IP Commercialization and Data Monetization from the University of Nottingham in 2019, a Bachelor's degree in Human and Medical Genetics from the same university in 2015, a Postgraduate Diploma in Genetic and Genomic Counseling from Cardiff University, and a Diploma in Data Science from Brain Station Academy.




